Oral Therapy in a Diabetic Patient With History of Infantile Hyperinsulinism

authors:

avatar Hossein Moravej 1 , avatar Zohreh Karamizadeh 1 , * , avatar Omid Aryani 2

Department of Pediatrics, Medical School, Shiraz University of Medical Sciences, Shiraz, IR Iran
Medical Genetics Department, Special Medical Center, Tehran, IR Iran
Iranian Journal of Pediatrics: Vol.25, issue 4; e268
published online: August 24, 2015
article type: Letter
received: December 25, 2013
revised: May 14, 2014
accepted: July 26, 2014
DOI: https://doi.org/10.5812/ijp.268

how to cite: Moravej H, Karamizadeh Z, Aryani O. Oral Therapy in a Diabetic Patient With History of Infantile Hyperinsulinism. Iran J Pediatr. 2015;25(4):e268. https://doi.org/10.5812/ijp.268.

Acknowledgements

References

  • 1.

    De Leon DD, Stanley CA. Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3(1):57-68. [PubMed ID: 17179930]. https://doi.org/10.1038/ncpendmet0368.

  • 2.

    Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008;54(2):256-63. [PubMed ID: 18156285]. https://doi.org/10.1373/clinchem.2007.098988.

  • 3.

    Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004;303(5662):1378-81. [PubMed ID: 14988562]. https://doi.org/10.1126/science.1089769.

  • 4.

    Flanagan SE, Kapoor RR, Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg. 2011;20(1):13-7. [PubMed ID: 21185998]. https://doi.org/10.1053/j.sempedsurg.2010.10.004.

  • 5.

    Zhang R, Hu C, Wang CR, Fang QC, Ma XJ, Jia WP, et al. [Scanning the HNF4A gene mutation from Chinese pedigrees with early- and/or multiple-onset diabetes]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23(4):406-9. [PubMed ID: 16883527].

  • 6.

    Mar-Heyming R, Miyazaki M, Weissglas-Volkov D, Kolaitis NA, Sadaat N, Plaisier C, et al. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2008;28(6):1193-9. [PubMed ID: 18340007]. https://doi.org/10.1161/ATVBAHA.107.160150.

  • 7.

    Barroso I, Luan J, Wheeler E, Whittaker P, Wasson J, Zeggini E, et al. Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies. Diabetes. 2008;57(11):3161-5. [PubMed ID: 18728231]. https://doi.org/10.2337/db08-0719.

  • 8.

    Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, et al. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med. 2009;26(5):466-73. [PubMed ID: 19646184]. https://doi.org/10.1111/j.1464-5491.2009.02720.x.